Onyx Pharmaceuticals, Inc.
249 E. Grand Avenue
South San Francisco
California
94080
United States
Tel: 650-266-0000
Fax: 650-266-0100
Website: http://www.onyx-pharm.com/
About Onyx Pharmaceuticals, Inc.
About Onyx Pharmaceuticals, Inc.Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com. Onyx Pharmaceuticals is on Twitter. Sign up to follow our Twitter feed @OnyxPharm at http://twitter.com/OnyxPharm.
354 articles about Onyx Pharmaceuticals, Inc.
-
Silence Therapeutics, Totus Medicines and Poseida Therapeutics all adjust as they welcome new members to their leadership teams.
-
Tarveda Therapeutics Appoints Jeffrey Bloss, M.D. as Chief Medical Officer
9/12/2018
Steven Hamburger, Ph.D. appointed as Vice President, Regulatory Affairs and Laura Mei appointed as Vice President, Clinical Operations.
-
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
8/16/2018
Synthorx, Inc. today announced the appointment of Joseph Leveque, M.D., as chief medical officer.
-
Gamida Cell Expands Leadership Team with Appointments of Tzvi Palash as Chief Operating Officer and John Schick as Vice President of Market Access
7/23/2018
Gamida Cell today announced the appointments of Tzvi Palash as chief operating officer (COO) and John D. Schick as vice president, market access.
-
It’s a super-busy week for biotech initial public offerings (IPOs) with six companies raking in a total of around $568 million.
-
Onyx Helps Accelerate TopiVert’s Compounds To Clinic
7/21/2017
-
Google's Verily Employees Make Themselves at Home at Onyx's Former HQ
3/24/2017
-
A Look at Amgen and Its $10 Billion Flop Onyx
11/3/2016
-
Google's Verily to Lease Onyx's Old Space in South San Francisco, Campus Can House Up to 1,000
2/19/2016
-
Embattled Theranos, Layoffs at Onyx And Other Events Shaped the Bay Area Biotech Community in 2015
1/4/2016
-
PRC Clinical To Host Expert Panel On “The Road To Econsent” At Onyx
10/21/2015
-
MPM Capital Appoints Pablo J. Cagnoni, M.D., Former OnyxPresident, As Managing Director And CEO Of MPM Immunotherapy Portfolio Company Vesuvius.
5/21/2015
-
MPM Capital Appoints Pablo J. Cagnoni, M.D., Former Onyx President, As Managing Director And CEO Of MPM Immunotherapy Portfolio Company Vesuvius.
5/20/2015
-
Amgen Will Shutter SSF Onyx Site, Lay Off At Least 300
3/16/2015
-
Fate Unknown for Remaining 200 Onyx Employees; Will They Head to Washington State?
3/13/2015
-
The Reason Why Onyx's Experiment To Become The Next Genentech Failed
3/12/2015
-
Medtronic Initiates Pivotal Studies Of Resolute Onyx Drug-Eluting Stent In United States
3/12/2015
-
Why Ex-Onyx CEO And Big Pharma Are Taking On Brain Diseases
2/13/2015
-
Ex-Onyx Pharmaceuticals, Inc. CEO Leads MA Biotech Startup
12/16/2014
-
Amgen And Onyx Pharmaceuticals, Inc. Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
12/8/2014